CORE-OM
CORE-OM (Clinical Outcomes in Routine Evaluation - Outcome Measure) is a widely used psychometric tool designed to assess the effectiveness of psychological therapies and interventions. It is a self-report questionnaire that measures a range of psychological problems and well-being.
Development[edit]
The CORE-OM was developed in the late 1990s by a team of researchers led by Chris Evans and Michael Barkham. The development process involved extensive consultation with clinicians and researchers to ensure the measure was comprehensive and applicable across different therapeutic settings.
Structure[edit]
The CORE-OM consists of 34 items that cover four main domains:
Each item is rated on a 5-point scale ranging from "Not at all" to "Most or all of the time." The measure is designed to be completed by clients before and after therapy to assess changes in their psychological state.
Scoring[edit]
The CORE-OM provides a total score as well as subscale scores for each of the four domains. Higher scores indicate greater levels of distress or dysfunction. The measure is designed to be sensitive to changes over time, making it useful for tracking progress in therapy.
Applications[edit]
The CORE-OM is used in a variety of settings, including:
It is particularly valued for its ability to provide a comprehensive overview of a client's psychological state, making it useful for both clinical assessment and research purposes.
Validation[edit]
The CORE-OM has been validated in numerous studies and has been translated into several languages. It is considered a reliable and valid measure of psychological distress and well-being.
Related Measures[edit]
Several related measures have been developed based on the CORE-OM, including:
- CORE-10
- CORE-SF
- YP-CORE (for young people)
See Also[edit]
References[edit]
External Links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian